BlackRock Investment Management’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.29M Sell
91,261
-1,250
-1% -$29.5K ﹤0.01% 2141
2016
Q3
$2.16M Sell
92,511
-93
-0.1% -$2.19K ﹤0.01% 2093
2016
Q2
$1.85M Buy
92,604
+5,982
+7% +$112K ﹤0.01% 2163
2016
Q1
$1.47M Buy
86,622
+2,004
+2% +$41.1K ﹤0.01% 2202
2015
Q4
$1.88M Buy
84,618
+549
+0.7% +$11.4K ﹤0.01% 2128
2015
Q3
$1.43M Sell
84,069
-1,102
-1% -$17.2K ﹤0.01% 2323
2015
Q2
$1.17M Buy
85,171
+14,924
+21% +$198K ﹤0.01% 2653
2015
Q1
$962K Sell
70,247
-392
-0.6% -$4.52K ﹤0.01% 2542
2014
Q4
$747K Buy
70,639
+323
+0.5% +$3.82K ﹤0.01% 2743
2014
Q3
$879K Buy
70,316
+2,475
+4% +$34.5K ﹤0.01% 2612
2014
Q2
$928K Buy
67,841
+730
+1% +$9.54K ﹤0.01% 2659
2014
Q1
$810K Buy
67,111
+811
+1% +$9.29K ﹤0.01% 2666
2013
Q4
$815K Sell
66,300
-2,752
-4% -$32.3K ﹤0.01% 2649
2013
Q3
$702K Buy
69,052
+730
+1% +$6.83K ﹤0.01% 2698
2013
Q2
$614K Buy
+68,322
New +$688K ﹤0.01% 2719

Other funds holding OME

BlackRock Investment Management's OME Position: Q4 2016 in Review

BlackRock Investment Management reduced its Omega Protein (OME) stake by 1.4% in Q4 2016, selling an estimated $29.5K and leaving 91,261 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

BlackRock Investment Management first reported a position in OME in Q2 2013 and has held it in 15 quarters since. 142 funds tracked by Wall St. Rank hold OME as of Q4 2016.

  • BlackRock Investment Management held 91,261 shares of Omega Protein worth $2.29M as of Q4 2016.
  • BlackRock Investment Management sold 1,250 Omega Protein shares in Q4 2016, an estimated $29.5K.
  • Omega Protein made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2141 holding.
  • BlackRock Investment Management first reported a position in Omega Protein in Q2 2013 and has held it in 15 quarters since.
  • 142 funds tracked by Wall St. Rank held Omega Protein as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.